in3

in3

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (Yesterday)
The goal of this webinar and discussion is to provide insight into the combined use of in silico and in vitro evide… https://t.co/W3hE1Cm95K
Edelweiss Connect (Yesterday)
#SaferWorldbyDesign presents: Skin safety assessment according to OECD guidelines Join us on December 17 for a we… https://t.co/oGymiPDVp0
Edelweiss Connect (2 days ago)
JRC Data Visualization: Extrapolating from acute to chronic toxicity in vitro An important question that was addre… https://t.co/B5Ius3qtDk
Edelweiss Connect (2 days ago)
#SaferWorldbyDesign webinar: In Silico solutions for drug discovery Presented by @Maieutix1 #insilico… https://t.co/Ya5J0ySQ0Q
Edelweiss Connect (2 weeks ago)
See why @wepredic @Biopredic_Intl #HepaRG™ cell model is the best for NAFLD investigations #SaferWorldbyDesign… https://t.co/pzgJbUhY7d

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA